We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NOXXON is Awarded Research and Development Grant for First-in-Human Clinical Trial with Spiegelmer® NOX-A12

News   Sep 04, 2009

 
NOXXON is Awarded Research and Development Grant for First-in-Human Clinical Trial with Spiegelmer® NOX-A12
 
 
 

RELATED ARTICLES

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

Treatment Eliminates Nicotine Addiction in Preclinical Tests

News

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

READ MORE

Retina Restoration Could Return Vision to Our Canine Friends

News

A stem cell-based approach is being developed to treat blindness in dogs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE